Acute gastroenteritis is a diarrheal disease of rapid onset.
Viruses are one of the common causes of gastroenteritis.
Rotavirus, enteric adenovirus serotypes 40 & 41, astrovirus and calicivirus (eg "Norwalk-like" virus) are the established viral agents causing gastroenteritis.
Rotavirus is the most common pathogen causing diarrhea in patients 3-24 months old.
Patients <3 months old are protected by maternal rotavirus antibodies that are passed transplacentally and possibly by breastfeeding.
Transmission is through fecal-oral route.
Incubation period may vary from 1-10 days depending on the causative agent.

Supportive Therapy

Oral Rehydration Solution (ORS)

  • The formula recommended by the World Health Organization (WHO)
    • Concentration of: 75 mEq/L sodium, 75 mmol/L glucose w/ total osmolarity of 245 mOsm/L
    • Lower osmolarity that is proportionally reduced sodium & glucose concentrations
    • The formulation has been shown to reduce vomiting & the need for intravenous (IV) fluids
  • As effective as IV fluids in rehydrating patients with mild to moderate dehydration
  • Severe vomiting, abdominal ileus & in state of hemodynamic shock are contraindications to oral rehydration solution

Intravenous (IV) Fluids or Nasogastric (NG) Oral Rehydration Solution (ORS)

  • Given for 4-6 hours or until adequate hydration is achieved
  • Recommended in the following patients:
    • Severely dehydrated
    • In whom oral hydration has failed due to severe vomiting
    • Patients with intestinal ileus or intestinal obstruction
  • Nasogastric feeding allows continuous oral rehydration solution administration at a slow & steady amount

Minimal or No Dehydration

  • Replace fluid losses by giving 60-120 mL of oral rehydration solution for each diarrheal stool or vomiting episode in patients who weigh <10 kg
  • For a patient with body weight of >10 kg, administer 120-240 mL of oral rehydration solution for each episode of fluid loss
  • Continue breastfeeding or resume age-appropriate feeding

Mild to Moderate Dehydration

  • Administer 50-100 mL of ORS/kg body weight over 3-4 hours to replace estimated fluid deficit
  • Give additional oral rehydration solution to restore ongoing fluid loss; may use the recommended amount as with minimal dehydration
  • Several trials support the use of nasogastric oral rehydration solution feeding even in patients with continuous vomiting or with presence of oral ulcers
  • Rapid IV hydration may also be administered

Severe Dehydration

  • Start patient on rapid IV rehydration
  • Administer 20 mL/kg body weight of IV lactated Ringer’s solution or normal saline solution (0.9% NaCl) until pulse, perfusion & mental status return to normal, followed by 100 mL/kg body weight of oral rehydraiton solution for 4 hours or 5% dextrose ½ normal saline IV at 2x maintenance fluid rates
    • Alternatively, give 100 mL/kg body weight. Then, for infants <1 year give 30 mL/kg/body weight within the 1st hour, followed by 70 mL/kg/body weight within 5 hours. For children >1 year, 30 mL/kg/body weight IV fluid may be given within the 1st 30 minutes, followed by 70 mL/kg/body weight within 2.5 hours
    • Administration of oral rehydration solution (ORS) may encourage early resumption of feeding
    • Study shows that giving of oral rehydration solution (ORS) may lead to rapid resolution of acidosis compared to IV fluid
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Editor's Recommendations
Most Read Articles
Audrey Abella, 31 Jan 2017
Nonsteroidal anti-inflammatory drug (NSAID) treatment for patent ductus arteriosus (PDA) in preterm infants did not reduce the odds of mortality or bronchopulmonary dysplasia (BPD), a recent US study found.
Jairia Dela Cruz, 13 Oct 2016
Children born to obese mothers are at increased risk of developing autism spectrum disorder (ASD) compared with children born to normal-weight mothers, according to data from a review and meta-analysis.
Yap Te-Lu, Anette Sundfor Jacobsen, 01 Oct 2013

Antenatal hydronephrosis (ANH) is a general term used to describe the dilatation of the fetal renal pelvis and/or its calyces. In pelviectasis, there is only dilatation of the renal pelvis; while in caliectasis, there is dilatation of the calyces. ANH is the most commonly diagnosed congenital urinary tract anomaly, which is detected by prenatal screening in 1–5% of all pregnancies